Filter
1303
Text search:
pharmaceutical
policies
Featured
118
359
Language
Document type
634
294
184
81
60
15
12
11
6
3
3
Countries / Regions
62
60
54
40
36
36
32
31
27
23
22
21
20
19
19
19
17
17
16
15
14
14
13
13
12
12
11
10
10
9
9
7
7
7
7
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
578
69
63
59
31
19
11
Toolboxes
156
103
102
72
69
44
35
32
31
26
23
22
21
19
14
14
11
9
7
5
4
4
3
3
1
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Bull World Health Organ 2017;95:594–598
Accessed November, 2017
Therapeutics Information and Pharmacovigilance Centre | TIPC
Mapping Report - Catalonia (Spain).
8–18 December 2015
Pan African Medical Journal 2017;27:215. doi: 10.11604/pamj.2017.27.215.12994
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
N°46/2012 of 14/01/2013 - Official Gazette n° Special of 17/01/2013 - LAW No 45/2012 OF 14/01/2013 ON ORGANISATION, FUNCTIONING AND COMPETENCE OF THE COUNCIL OF PHARMACISTS
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I
...
